Could a cheaper hormone make IVF more affordable?

NCT ID NCT07771283

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This trial is testing whether a more affordable hormone protocol can work as well as standard IVF stimulation. Typically, IVF uses expensive gonadotropins to stimulate the ovaries to produce multiple eggs. The study compares a protocol that replaces a large portion of these with human chorionic gonadotropin (hCG) against standard protocols. Researchers will compare the number and quality of eggs and embryos, as well as pregnancy and live birth rates, to see if the cheaper approach is just as effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Human chorionic gonadotropin (hCG) used as a substitute for part of the standard gonadotropin stimulation in IVF
What this could lead to
If effective, this could make IVF more affordable by reducing the need for expensive gonadotropin medications, potentially expanding access to fertility treatment.
What could go wrong
The trial is early and may show that hCG is less effective than standard protocols. There is also a risk of ovarian hyperstimulation syndrome (OHSS), though the study monitors for this.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTROLLED OVARIAN SIMULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • LTD "EKODNIPRO" Medical Centre "Medical Plaza"

    Dnipro, Ukraine

  • LTD "Yuzko" Yuzko Medical Center

    Chernivtsi, Ukraine

  • Sali international school of fertility medicine

    Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.